GLP-1 receptor agonists mimic incretin hormones to enhance insulin secretion, suppress glucagon, slow gastric emptying, and promote satiety for diabetes and weight management
This can stress the mitochondria the energy factories inside your cells slow metabolic recovery, and impair your body's natural detoxification systems unless the liver, bile flow, and antioxidant systems are supported
Start with the intended product claim and format
G., Lee, B.-R., Koprivova, A., Matthewman, C
The gastrointestinal effects typically emerge during dose escalation and often diminish over time as the body adapts to the medication
The difference often comes down to whether patients need to be their own advocates or whether their doctor starts the conversation